FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report | BMC Medical Genomics

  • Ou A, Yung WKA, Majd N. Molecular mechanisms of treatment resistance in glioblastoma. Int J Mol Sci. 2021;22(1):351.

    CAS 

    Google Scholar
     

  • Wang G-M, Cioffi G, Patil N, Waite KA, Lanese R, Ostrom QT, et al. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. Neuro Oncol. 2022;24(2):302–10.

    CAS 

    Google Scholar
     

  • Zeng T, Li L, Zhou Y, Gao L. Exploring long noncoding RNAs in glioblastoma: regulatory mechanisms and clinical potentials. Int J Genom. 2018;2018:1–13.


    Google Scholar
     

  • Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–61.

    CAS 

    Google Scholar
     

  • Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–8.

    CAS 

    Google Scholar
     

  • Wang R, Zhang S, Chen X, Li N, Li J, Jia R, et al. CircNT5E acts as a sponge of miR-422a to promote glioblastoma tumorigenesis. Can Res. 2018;78(17):4812–25.

    CAS 

    Google Scholar
     

  • Hsiao K-Y, Lin Y-C, Gupta SK, Chang N, Yen L, Sun HS, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Can Res. 2017;77(9):2339–50.

    CAS 

    Google Scholar
     

  • Han D, Li J, Wang H, Su X, Hou J, Gu Y, et al. Circular RNA circMTO1 acts as the sponge of MicroRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151–64.

    CAS 

    Google Scholar
     

  • Zheng J, Liu X, Xue Y, Gong W, Ma J, Xi Z, et al. TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1 beta/Derlin-1 pathway. J Hematol Oncol. 2017;10:351.


    Google Scholar
     

  • Yu J, Xu Q-G, Wang Z-G, Yang Y, Zhang L, Ma J-Z, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–27.

    CAS 

    Google Scholar
     

  • Li Y, Chen J, Chen Z, Xu X, Weng J, Zhang Y, et al. CircGLIS3 promotes high-grade glioma invasion via modulating Ezrin phosphorylation. Front Cell Dev Biol. 2021;9:663207.


    Google Scholar
     

  • Long H, Liang C, Zhang Xa, Fang L, Wang G, Qi S, et al. Prediction and analysis of key genes in glioblastoma based on bioinformatics. Biomed Res Int. 2017;2017.

  • Xiong D-D, Dang Y-W, Lin P, Wen D-Y, He R-Q, Luo D-Z, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16:1–21.


    Google Scholar
     

  • Liu Y, Zhu J, Ma X, Han S, Xiao D, Jia Y, et al. ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection. J Cell Physiol. 2019;234(5):7128–40.

    CAS 

    Google Scholar
     

  • Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol. 2012;16(5):284–7.

    CAS 

    Google Scholar
     

  • Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M, Liu J, et al. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Int J Biol Sci. 2018;14(2):124–36.

    CAS 

    Google Scholar
     

  • Li T, Wernersson R, Hansen RB, Horn H, Mercer J, Slodkowicz G, et al. A scored human protein–protein interaction network to catalyze genomic interpretation. Nat Methods. 2017;14(1):61–4.

    CAS 

    Google Scholar
     

  • Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437.

    CAS 

    Google Scholar
     

  • Wagner AH, Coffman AC, Ainscough BJ, Spies NC, Skidmore ZL, Campbell KM, et al. DGIdb 2.0: mining clinically relevant drug–gene interactions. Nucleic Acids Res. 2016;44(D1):D1036–44.

    CAS 

    Google Scholar
     

  • Wang Y, Zeng T. Response to: practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2013;14(1):391.


    Google Scholar
     

  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.


    Google Scholar
     

  • Chen Y, Liang Y, Chen Y, Ouyang S, Liu K, Yin W. Identification of prognostic metabolism-related genes in clear cell renal cell carcinoma. J Oncol. 2021;2021:2042114.


    Google Scholar
     

  • Li J, Yang Z-L, Ren X, Zou Q, Yuan Y, Liang L, et al. ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder. J Mol Histol. 2014;45(1):47–57.


    Google Scholar
     

  • Li Y, Liu Z, Zhang Y. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma. BMC Gastroenterol. 2021;21(1):1–14.


    Google Scholar
     

  • Peng Q, Wang L, Zhao D, Lv Y, Wang H, Chen G, et al. Overexpression of FZD1 is associated with a good prognosis and resistance of sunitinib in clear cell renal cell carcinoma. J Cancer. 2019;10(5):1237–51.

    CAS 

    Google Scholar
     

  • Su W, Ye H, Wu F, Mo Y, Li S, Mai Z, et al. Low expression of FZD1 correlates with poor prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2016;9(8):8335–42.

    CAS 

    Google Scholar
     

  • Yang L, Yang Z, Li D, Liu Z, Zou Q, Yuan Y, et al. Overexpression of FZD1 and CAIX are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Pathol Oncol Res. 2018;24(4):899–906.

    CAS 

    Google Scholar
     

  • Chang VHS, Chu P-Y, Peng S-L, Mao T-L, Shan Y-S, Hsu C-F, et al. Kruppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. Am J Pathol. 2012;181(2):423–30.

    CAS 

    Google Scholar
     

  • Lin Y-M, Yeh K-T, Yeh C-M, Soon M-S, Hsu L-S. KLF10 functions as an independent prognosis factor for gastric cancer. Medicina Lithuania. 2022;58(6):711.


    Google Scholar
     

  • Yeh C-M, Lee Y-J, Ko P-Y, Lin Y-M, Sung W-W. High expression of KLF10 is associated with favorable survival in patients with oral squamous cell carcinoma. Medicina Lithuania. 2021;57(1):17.


    Google Scholar
     

  • Zhao Z, Zhan Y, Jing L, Zhai H. KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma. Oncol Lett. 2022;23(6):1–11.


    Google Scholar
     

  • Ferraro B, Bepler G, Sharma S, Cantor A, Haura EB. EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer. J Clin Oncol. 2005;23(9):1921–6.

    CAS 

    Google Scholar
     

  • Cloughesy TF, Cavenee WK, Mischel PS. Glioblastoma: from molecular pathology to targeted treatment. In: Abbas AK, Galli SJ, Howley PM, editors. Annual review of pathology: mechanisms of disease, Vol 9. Annual review of pathology-mechanisms of disease. 92014. p. 1–25.

  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

    CAS 

    Google Scholar
     

  • Zanca C, Villa GR, Benitez JA, Thorne AH, Koga T, D’Antonio M, et al. Glioblastoma cellular cross-talk converges on NF-kappa B to attenuate EGFR inhibitor sensitivity. Genes Dev. 2017;31(12):1212–27.

    CAS 

    Google Scholar
     

  • Zhao L, Wang W, Xu L, Yi T, Zhao X, Wei Y, et al. Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer (vol 38, pg 2305, 2019). Oncogene. 2019;38(47):7279–80.

    CAS 

    Google Scholar
     

  • Lu D-H, Yang J, Gao L-K, Min J, Tang J-M, Hu M, et al. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial-mesenchymal transition. Oncol Rep. 2019;41(2):917–27.

    CAS 

    Google Scholar
     

  • Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460–9.

    CAS 

    Google Scholar
     

  • Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer. 2021;20(1):1–23.


    Google Scholar
     

  • Grabacka M, Wieczorek J, Michalczyk-Wetula D, Malinowski M, Wolan N, Wojcik K, et al. Peroxisome proliferator-activated receptor alpha (PPAR alpha) contributes to control of melanogenesis in B16 F10 melanoma cells. Arch Dermatol Res. 2017;309(3):141–57.

    CAS 

    Google Scholar
     

  • Suyama K, Naito Y, Yoh K, Niho S, Goto K, Ohmatsu H, et al. Development of cushing’s syndrome during effective chemotherapy for small cell lung cancer. Intern Med. 2011;50(4):335–8.


    Google Scholar
     

  • Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. 2019;15(9):525–34.


    Google Scholar
     

  • Latour M, Her N-G, Kesari S, Nurmemmedov E. WNT signaling as a therapeutic target for glioblastoma. Int J Mol Sci. 2021;22(16):8428.

    CAS 

    Google Scholar
     

  • Jung Y-S, Park J-I. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond beta-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183–91.

    CAS 

    Google Scholar
     

  • Kalani MYS, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL, et al. Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci. 2008;105(44):16970–5.

    CAS 

    Google Scholar
     

  • Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang J, et al. Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/β-catenin pathway by scaffolding EZH2. Clin Cancer Res. 2018;24(3):684–95.

    CAS 

    Google Scholar
     

  • Suwala AK, Hanaford A, Kahlert UD, Maciaczyk J. Clipping the wings of glioblastoma: modulation of WNT as a novel therapeutic strategy. J Neuropathol Exp Neurol. 2016;75(5):388–96.

    CAS 

    Google Scholar
     

  • Sareddy GR, Kesanakurti D, Kirti PB, Babu PP. Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/beta-catenin/Tcf signaling pathway in human glioblastoma cells. Neurochem Res. 2013;38(11):2313–22.

    CAS 

    Google Scholar
     

  • Yin YQ, Cai JJ, Meng FD, Sui CG, Jiang YH. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. Cancer Biol Ther. 2018;19(4):306–15.

    CAS 

    Google Scholar
     

  • Liborio-Kimura TN, Jung HM, Chan EKL. miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. Oral Oncol. 2015;51(2):151–7.

    CAS 

    Google Scholar
     

  • Bi W, Huang JY, Nie CL, Liu B, He GQ, Han JH, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of -catenin pathway. J Exp Clin Cancer Res. 2018;37:1–9.


    Google Scholar
     

  • Barbagallo D, Condorelli A, Ragusa M, Salito L, Sammito M, Banelli B, et al. Dysregulated miR-671-5p/CDR1-AS/CDR1/VSNL1 axis is involved in glioblastoma multiforme. Oncotarget. 2016;7(4):4746–59.


    Google Scholar
     

  • Kurscheid S, Bady P, Sciuscio D, Samarzija I, Shay T, Vassallo I, et al. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome Biol. 2015;16:1–15.


    Google Scholar
     

  • Li F, Jin D, Guan L, Zhang C-C, Wu T, Wang Y-J, et al. CEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251. Neurosci Lett. 2019;705:80–6.

    CAS 

    Google Scholar
     

  • Amaral RF, Geraldo LHM, Einicker-Lamas M, Spohr TCLDSE, Mendes F, Lima FRS. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA(1)receptor. J Neurochem. 2021;156(4):499–512.


    Google Scholar
     

  • Wu F, Jiao J, Liu F, Yang Y, Zhang S, Fang Z, et al. Hypermethylation of Frizzled1 is associated with Wnt/beta-catenin signaling inactivation in mesenchymal stem cells of patients with steroid-associated osteonecrosis. Exp Mol Med. 2019;51:1–9.


    Google Scholar
     

  • Han SY, Pang MF, Nelson CM. Substratum stiffness tunes proliferation downstream of Wnt3a in part by regulating integrin-linked kinase and frizzled-1. J Cell Sci. 2018;131(8):210476.


    Google Scholar
     

  • Planutis K, Planutiene M, Nguyen AV, Moyer MP, Holcombe RF. Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med. 2013;11:1–7.


    Google Scholar
     

  • Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, et al. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene. 2009;28(23):2245–56.

    CAS 

    Google Scholar
     

  • Zhang H, Jing X, Wu X, Hu J, Zhang X, Wang X, et al. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anticancer Drugs. 2015;26(7):706–15.

    CAS 

    Google Scholar
     

  • Zhang H, Zhang X, Wu X, Li W, Su P, Cheng H, et al. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/beta-catenin pathway. Cancer Lett. 2012;323(1):106–13.

    CAS 

    Google Scholar
     

  • Memon A, Lee WK. KLF10 as a tumor suppressor gene and its TGF-beta signaling. Cancers. 2018;10(6):161.


    Google Scholar
     

  • Hsu Y-C, Ho C, Shih Y-H, Ni W-C, Li Y-C, Chang H-C, et al. Knockout of KLF10 ameliorated diabetic renal fibrosis via downregulation of DKK-1. Molecules. 2022;27(9):2644.

    CAS 

    Google Scholar
     

  • You M, Zhang L, Zhang X, Fu Y, Dong X. MicroRNA-197-3p inhibits the osteogenic differentiation in osteoporosis by down-regulating KLF 10. Clin Interv Aging. 2021;16:107–17.

    CAS 

    Google Scholar
     

  • Papadakis KA, Krempski J, Svingen P, Xiong Y, Sarmento OF, Lomberk GA, et al. Kruppel-like factor KLF10 deficiency predisposes to colitis through colonic macrophage dysregulation. Am J Physiol Gastrointest Liver Physiol. 2015;309(11):G900–9.

    CAS 

    Google Scholar
     

  • Zhou MM, Chen JQ, Zhang H, Liu HL, Yao H, Wang XM, et al. KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p. Int J Biol Sci. 2020;16(12):2063–71.

    CAS 

    Google Scholar
     

  • Marrero-Rodriguez D, Taniguchi-Ponciano K, Subramaniam M, Hawse JR, Pitel KS, Arreola-DelaCruz H, et al. Kruppel-like factor 10 participates in cervical cancer immunoediting through transcriptional regulation of pregnancy-specific beta-1 glycoproteins. Sci Rep. 2018;8:9445.


    Google Scholar
     

  • Diamond JR, Becerra C, Richards D, Mita A, Osborne C, O’Shaughnessy J, et al. Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer. Breast Cancer Res Treat. 2020;184(1):53–62.

    CAS 

    Google Scholar
     

  • Davis SL, Cardin DB, Shahda S, Lenz HJ, Dotan E, O’Neil BH, et al. A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer. Invest New Drugs. 2020;38(3):821–30.

    CAS 

    Google Scholar
     

  • Wieland A, Trageser D, Gogolok S, Reinartz R, Höfer H, Keller M, et al. Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res. 2013;19(15):4124–36.

    CAS 

    Google Scholar
     

  • Cheng B, Morales LD, Zhang Y, Mito S, Tsin A. Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line. PLoS ONE. 2017;12(9): e0184324.


    Google Scholar
     

  • Oh HC, Shim JK, Park J, Lee JH, Choi RJ, Kim NH, et al. Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres. J Cancer Res Clin Oncol. 2020;146(11):2817–28.

    CAS 

    Google Scholar
     

  • Kumar SU, Gopinath P. Controlled delivery of bPEI-niclosamide complexes by PEO nanofibers and evaluation of its anti-neoplastic potentials. Colloids Surf B Biointerfaces. 2015;131:170–81.

    CAS 

    Google Scholar
     

  • Kraljic K, Jelic D, Ziher D, Cvrtila A, Dragojevic S, Sinkovic V, et al. Benzoxaboroles-novel autotaxin inhibitors. Molecules. 2019;24(19):3419.

    CAS 

    Google Scholar
     

  • Read more here: Source link